Selective autophagy as a potential therapeutic target for neurodegenerative disorders

A Scrivo, M Bourdenx, O Pampliega… - The Lancet …, 2018 - thelancet.com
Cells rely on surveillance systems such as autophagy to handle protein alterations and
organelle damage. Dysfunctional autophagy, an evolutionarily conserved cellular …

α-Synuclein pathology in Parkinson's disease and related α-synucleinopathies

MX Henderson, JQ Trojanowski, VMY Lee - Neuroscience letters, 2019 - Elsevier
Over 20 years ago, the synaptic protein α-synuclein was identified as the primary component
of the Lewy bodies (LBs) that are a sine qua non of Parkinson's disease (PD). Since that …

Inflammasome inhibition prevents α-synuclein pathology and dopaminergic neurodegeneration in mice

R Gordon, EA Albornoz, DC Christie… - Science translational …, 2018 - science.org
Parkinson's disease (PD) is characterized by a profound loss of dopaminergic neurons in
the substantia nigra, accompanied by chronic neuroinflammation, mitochondrial dysfunction …

Bidirectional gut-to-brain and brain-to-gut propagation of synucleinopathy in non-human primates

ML Arotcarena, S Dovero, A Prigent, M Bourdenx… - Brain, 2020 - academic.oup.com
In Parkinson's disease, synucleinopathy is hypothesized to spread from the enteric nervous
system, via the vagus nerve, to the CNS. Here, we compare, in baboon monkeys, the …

Neuronal activity induces glucosylceramide that is secreted via exosomes for lysosomal degradation in glia

L Wang, G Lin, Z Zuo, Y Li, SK Byeon, A Pandey… - Science …, 2022 - science.org
Recessive variants in GBA1 cause Gaucher disease, a prevalent form of lysosome storage
disease. GBA1 encodes a lysosomal enzyme that hydrolyzes glucosylceramide (GlcCer) …

The Role of Cholesterol in α‐Synuclein and Lewy Body Pathology in GBA1 Parkinson's Disease

P García‐Sanz, J MFG Aerts… - Movement Disorders, 2021 - Wiley Online Library
Parkinson's disease (PD) is a progressive neurodegenerative disease where dopaminergic
neurons in the substantia nigra are lost, resulting in a decrease in striatal dopamine and …

Glucocerebrosidase activity modulates neuronal susceptibility to pathological α-synuclein insult

MX Henderson, S Sedor, I McGeary, EJ Cornblath… - Neuron, 2020 - cell.com
Mutations in the GBA1 gene are the most common genetic risk factor for Parkinson's disease
(PD) and dementia with Lewy bodies (DLB). GBA1 encodes the lysosomal lipid hydrolase …

[HTML][HTML] Glucocerebrosidase-associated Parkinson disease: Pathogenic mechanisms and potential drug treatments

ME Gegg, E Menozzi, AHV Schapira - Neurobiology of Disease, 2022 - Elsevier
Dysfunction of the endolysosomal system is implicated in the pathogenesis of both sporadic
and familial Parkinson disease (PD). Variants in genes encoding lysosomal proteins have …

The role of glucocerebrosidase in Parkinson disease pathogenesis

ME Gegg, AHV Schapira - The FEBS journal, 2018 - Wiley Online Library
GBA encodes the lysosomal enzyme glucocerebrosidase (GCase), an enzyme involved in
sphingolipid metabolism. Mutations in the GBA gene are numerically the most important risk …

Astrocyte dysfunction in Parkinson's disease: from the perspectives of transmitted α-synuclein and genetic modulation

C Wang, T Yang, M Liang, J Xie, N Song - Translational …, 2021 - Springer
Parkinson's disease (PD) is a common neurodegenerative disorder that primarily affects the
elderly. While the etiology of PD is likely multifactorial with the involvement of genetic …